Sign In
Buy HQL
$18.63
+0.290 (+1.58%)
At Close: Jun 23, 2026
Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution
02:18pm, Thursday, 09'th Jul 2020
On July 9, 2020, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is July 20, 2020 and the payable dat
Wells Fargo & Company MN Increases Stock Position in Tekla Life Sciences Investors (NYSE:HQL)
05:05am, Monday, 06'th Jul 2020
Wells Fargo & Company MN grew its stake in shares of Tekla Life Sciences Investors (NYSE:HQL) by 3.5% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission.
Royal Bank of Canada Boosts Stock Position in Tekla Healthcare Investors (NYSE:HQH)
09:32am, Wednesday, 01'st Jul 2020
Royal Bank of Canada raised its position in shares of Tekla Healthcare Investors (NYSE:HQH) by 0.2% during the 1st quarter, Holdings Channel reports. The firm owned 461,726 shares of the financial ser
Tekla Healthcare Investors Paid Distribution
03:45pm, Tuesday, 30'th Jun 2020
On June 30, 2020, Tekla Healthcare Investors paid a distribution of $0.41 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return o
The Reopening Killed The V-Shaped Recovery
07:43am, Monday, 29'th Jun 2020
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
Worldwide Life Sciences Market Protective Clothing Industry to 2028 - Impact of COVID-19 - ResearchAndMarkets.com
12:00am, Tuesday, 23'rd Jun 2020
The
Geode Capital Management LLC Grows Stock Holdings in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)
07:16am, Sunday, 21'st Jun 2020
Geode Capital Management LLC raised its stake in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) by 16.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exc
5 Best CEFs To Buy This Month (June 2020)
09:34am, Saturday, 20'th Jun 2020
During the last few months, most closed-end funds have been hit hard. Moreover, their recovery had lagged the broader market, but more recently, they have been
MML Investors Services LLC Purchases 1,673 Shares of Tekla Healthcare Investors (NYSE:HQH)
07:20am, Friday, 19'th Jun 2020
MML Investors Services LLC boosted its position in shares of Tekla Healthcare Investors (NYSE:HQH) by 10.9% in the first quarter, according to the company in its most recent 13F filing with the Securi
Rockefeller Capital Management L.P. Acquires New Holdings in Tekla Healthcare Investors (NYSE:HQH)
05:44am, Wednesday, 10'th Jun 2020
Rockefeller Capital Management L.P. bought a new stake in Tekla Healthcare Investors (NYSE:HQH) during the first quarter, according to its most recent 13F filing with the SEC. The institutional invest
Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution
02:21pm, Monday, 08'th Jun 2020
On June 8, 2020, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is June 19, 2020 and the payable dat
3 months after its B round, Akouos files an IPO to the tune of $100M
12:20pm, Monday, 08'th Jun 2020
Boston-based hearing loss gene therapy biotech Akouos is gunning for a $100 million IPO amid a near invulnerable market for public-seeking biotechs.
Gilead builds case for filgotinib in active psoriatic arthritis
12:10pm, Monday, 08'th Jun 2020
Gilead and Galapagos have presented long-term midphase data on filgotinib in patients with active psoriatic arthritis. The analysis shows responses seen at 16 weeks were sustained out to 52 weeks afte
BIO: Nimbus CEO: 'We're not just a one-hit wonder'
12:00pm, Monday, 08'th Jun 2020
When Nimbus Therapeutics set up shop in 2009, it had to convince the industry—including its founding chief scientific officer—that virtual drug discovery could be a viable approach. Now, Nimbus is
